Early COVID drug trial halted as pandemic waned
NCT ID NCT04661540
Summary
This study aimed to test different doses of an experimental drug called Auxora in patients with life-threatening COVID-19 pneumonia who were on breathing machines. The main goal was to see how the drug affected the immune cells in the lungs and to check if it was safe. The trial was stopped early because there were not enough new COVID-19 hospitalizations to continue enrolling patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.